Platelet-derived TGF-β downregulates the tumor suppressor gene KLF6, leading to enhanced tumor cell proliferation and cell cycle progression in vitro as well as enhanced tumor cell growth in vivo [112]. The gene discussed is KLF6; the disease is neoplasm.